[1]SIEGEL RL,MILLER KD,JEMAL A.Cancer statistics,2020[J].CA Cancer J Clin,2020,70(1):7-30.
[2]马明月,吴瑾.上皮性卵巢癌预后因素的研究进展[J].现代肿瘤医学,2020,28(17):3085-3088.
MA MY,WU J.Research progress on prognostic factors of epithelial ovarian cancer[J].Modern Oncology,2020,28(17):3085-3088.
[3]张丽滢,李力.分子进化理论在卵巢癌发生及多药耐药的研究进展[J].中国肿瘤生物治疗杂志,2017,24(05):553-557.
ZHANG LY,LI L.Research progress of molecular evolution theory in the occurrence and multidrug resistance of ovarian cancer[J].Chinese Journal of Cancer Biotherapy,2017,24(05):553-557.
[4]LI X,WANG X.The emerging roles and therapeutic potential of exosomes in epithelial ovarian cancer[J].Mol Cancer,2017,16(1):92.
[5]刘姗,王静,刘路,等.卵巢癌复发治疗的研究进展[J].肿瘤药学,2019,9(02):189-192.
LIU S,WANG J,LIU L,et al.Research progress in the treatment of recurrence of ovarian cancer[J].Oncology Pharmacy,2019,9(02):189-192.
[6]褚雁鸿,刘芹,刘宝瑞.新抗原:开启肿瘤治疗性疫苗的新时代[J].肿瘤综合治疗电子杂志,2018,4(02):6-13.
CHU YH,LIU Q,LIU BR.Neoantigens:Opening a new era of tumor therapeutic vaccines[J].Electronic Journal of Comprehensive Cancer Treatment,2018,4(02):6-13.
[7]SILINA K,ZAYAKIN P,KALNINA Z,et al.Sperm-associated antigens as targets for cancer immunotherapy:expression pattern and humoral immune response in cancer patients[J].J Immunother,2011,34(1):28-44.
[8]COAN M,RAMPIONI VG,CESARATTO L,et al.Exploring the role of fallopian ciliated cells in the pathogenesis of high-grade serous ovarian cancer[J].Int J Mol Sci,2018,19(9):2512.
[9]MENG X,SUN X,LIU Z,et al.A novel era of cancer/testis antigen in cancer immunotherapy[J].Int Immunopharmacol,2021,98(98):107889.
[10]GORDEEVA O.Cancer-testis antigens:Unique cancer stem cell biomarkers and targets for cancer therapy[J].Semin Cancer Biol,2018,53(53):75-89.
[11]LIN S,LYU Y,ZHENG L,et al.Expression and prognosis of sperm-associated antigen 1 in human breast cancer[J].Onco Targets Ther,2021,14(14):2689-2698.
[12]BUECHLER S.Low expression of a few genes indicates good prognosis in estrogen receptor positive breast cancer[J].BMC Cancer,2009,9(9):243.
[13]XIAO C,LI M,HUANG Q,et al.SPAG9 promotes prostate cancer proliferation and metastasis via MAPK signaling pathway[J].Am J Transl Res,2019,11(8):5249-5260.
[14]NEILSON L,SCHNEIDER P,VAN DEERLIN P,et al.cDNA cloning and characterization of a human sperm antigen (SPAG6) with homology to the product of the Chlamydomonas PF16 locus[J].Genomics,1999,60(3):272-280.
[15]ZHENG DF,WANG Q,WANG JP,et al.The emerging role of sperm-associated antigen 6 gene in the microtubule function of cells and cancer[J].Mol Ther Oncolytics,2019,15(15):101-107.
[16]LI X,XU L,SUN G,et al.Spag6 mutant mice have defects in development and function of spiral ganglion neurons,apoptosis,and higher sensitivity to Paclitaxel[J].Sci Rep,2017,7(1):8638.
[17]LIU Y,ZHANG L,LI W,et al.The sperm-associated antigen 6 interactome and its role in spermatogenesis[J].Reproduction,2019,158(2):181-197.
[18]LIU G,CLARET FX,ZHOU F,et al.Jab1/COPS5 as a novel biomarker for diagnosis,prognosis,therapy prediction and therapeutic tools for human cancer[J].Front Pharmacol,2018,9(9):135.
[19]HE W,WANG X,CHEN L,et al.A crosstalk imbalance between p27kip1and its interacting molecules enhances breast carcinogenesis[J].Cancer Biother Radiopharm,2012,27(7):399-402.
[20]TOMODA K,KUBOTAU Y,ARATA Y,et al.The cytoplasmic shuttling and subsequent degradation of p27kip1 mediated by Jab1/CSN5 and the COP9 signalosome complex[J].J Biol Chem,2002,277(3):2302-2310.
[21]KITCHEN MO,BRYAN RT,HAWORTH KE,et al.Methylation of HOXA9 and ISL1 predicts patient outcome in high-grade non-invasive bladder cancer[J].PLoS One,2015,10(9):e0137003.
[22]ZHANG R,ZHU H,YUAN Y,et al.SPAG6 promotes cell proliferation and inhibits apoptosis through the PTEN/PI3K/AKT pathway in Burkitt lymphoma[J].Oncol Rep,2020,44(5):2021-2030.
[23]LI W,MUKHERJEE A,WU J,et al.Sperm associated antigen 6 (SPAG6) regulates fibroblast cell growth,morphology,migration and ciliogenesis[J].Sci Rep,2015,5(5):16506.